CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn net income
Net income is the profit left for shareholders after every expense, interest and tax.
CytoDyn's net income for the twelve months ending Aug 31, 2026 was -$57.10M. For fiscal 2026 it was -$42.70M, down 1240.2% from the year before. The highest annual figure on record is $3.75M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$42.70M | -1240.2% |
| FY2025 | May 31, 2025 | $3.75M | – |
| FY2024 | May 31, 2024 | -$49.84M | – |
| FY2023 | May 31, 2023 | -$79.82M | – |
| FY2022 | May 31, 2022 | -$210.82M | – |
| FY2021 | May 31, 2021 | -$176.47M | – |
| FY2020 | May 31, 2020 | -$139.94M | – |
| FY2019 | May 31, 2019 | -$60.72M | – |
| FY2018 | May 31, 2018 | -$50.15M | – |
| FY2017 | May 31, 2017 | -$25.76M | – |
| FY2016 | May 31, 2016 | -$25.70M | – |
| FY2015 | May 31, 2015 | -$25.09M | – |
| FY2014 | May 31, 2014 | -$12.43M | – |
| FY2013 | May 31, 2013 | -$9.57M | – |
| FY2012 | May 31, 2012 | -$7.47M | – |
| FY2011 | May 31, 2011 | -$3.72M | – |
| FY2010 | May 31, 2010 | -$3.36M | – |
| FY2009 | May 31, 2009 | -$1.31M | – |
| FY2008 | May 31, 2008 | -$1.19M | – |
| FY2007 | May 31, 2007 | -$2.61M | – |
| FY2006 | May 31, 2006 | -$2.05M | – |
| FY2005 | May 31, 2005 | -$777.08K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$19.94M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$9.86M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$4.69M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$22.61M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$5.54M | -128.8% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$5.96M | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$4.76M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$4.77M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $19.23M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$16.79M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$11.92M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$9.56M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$11.57M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$26.50M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$20.99M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$84.12M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$41.29M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$40.08M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$45.34M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$70.07M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$37.58M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -$37.98M | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$30.83M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$73.14M | – |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$35.77M | – |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$14.86M | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$16.16M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$19.43M | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -$12.57M | – |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$14.31M | – |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$14.41M | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$9.62M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$17.95M | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$10.95M | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$11.63M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$6.83M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$8.11M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | -$5.26M | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | -$8.90M | – |
See a number that looks wrong?